Reaction

Strongyloidiasis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,600 reports · 88 co-occurring drugs

As of the last recalculation, Strongyloidiasis appears in 1,600 FAERS reports alongside 88 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 131.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Basiliximab	111	131.9	133.1
Valganciclovir Hydrochloride Powder,	67	74.5	74.9
Valganciclovir	71	51.2	51.4
Valganciclovir Hydrochloride	71	51.2	51.4
Tacrolimus Ointment 0.1%	376	51.0	51.2
Tacrolimus Extended-Release Capsules	376	50.9	51.1
Tacrolimus	406	44.8	45.0
Mycophenilic Acid	67	43.9	44.0
Mycophenolate Mofetil	345	41.9	42.0
Mycophenolate Mofetil Hydrochloride	345	41.8	41.9
Anti-Thymocyte Globulin (Rabbit)	24	39.3	39.4
Prednisolone	389	36.7	36.8
Prednisolone Oral	389	36.7	36.8
Prednisolone Oral Solution	389	36.7	36.8
Ganciclovir Sodium	27	33.7	33.8
Piperacillin And Tazobactam	32	33.2	33.3
Methylprednisolone	285	32.4	32.5
Mycophenolic Acid	75	31.9	32.0
Ganciclovir	23	29.6	29.7
Piperacillin Sodium,Tazobactam Sodium	54	27.4	27.4
Ampicillin	17	27.0	27.0
Ampicillin Sodium	17	27.0	27.0
Isoniazid	32	26.2	26.2
Cefazolin	18	25.9	26.0
Meropenem	58	24.4	24.4
Piperacillin Sodium And Tazobactam Sodium	33	22.3	22.4
Cefazolin Sodium	20	21.8	21.9
Ceftriaxone	53	21.7	21.7
Vincristine Sulfate	46	21.0	21.0
Ceftriaxone Sodium	58	20.4	20.4
Prednisone	521	19.5	19.5
Cefepime	21	19.3	19.3
Cefepime Hydrochloride	21	17.2	17.2
Dexamethasone Sodium Phosphate	12	15.5	15.5
Mercaptopurine	20	15.2	15.2
Lamivudine Oral	29	15.2	15.2
Raltegravir	19	15.1	15.2
Vancomycin	61	14.2	14.2
Cyclophosphamide Injection, Solution	173	14.1	14.1
Cyclophosphamide	173	14.1	14.1
Cyclophosphamide For Injection	173	14.1	14.1
Voriconazole Injection	23	14.0	14.0
Anti-Itch	68	13.7	13.7
Anti-Pruritic	68	13.7	13.7
Antipruritic (Anti-Itch)	68	13.7	13.7
Cool Relief Gel With Aloe	68	13.7	13.7
Drs. Hydrocortisone	68	13.7	13.7
Hydrocortisone Continuous Spray	68	13.7	13.7
Hydrocortisone Spray	68	13.7	13.7
Anti-Itch Cream	68	13.7	13.7
Hydrocortisone Lotion	68	13.7	13.7
Hydrocortisone Cream 1%	68	13.7	13.7
Hydrocortisone Cream 1/2%	68	13.7	13.7
Hydrocortisone 1%	68	13.7	13.7
Hydrocortisone Cream	68	13.7	13.7
Norepinephrine	11	13.5	13.5
Vancomycin Hydrochloride	64	13.1	13.1
Hydrocortisone Acetate	70	13.1	13.1
Lamivudine	30	12.9	12.9
Dexamethasone 1.5 Mg	245	12.7	12.7
Dexamethasone	245	12.5	12.5
Doxorubicin	81	12.4	12.4
Daspone	9	12.1	12.1
Dapsone Gel, 5%	9	12.1	12.1
Nystatin Ointment	23	11.6	11.6
Nystatin Cream	23	11.5	11.6
Daptomycin	8	11.3	11.3
Rituximab	165	11.2	11.2
Dapsone	9	11.0	11.0
Norepinephrine Bitartrate	12	10.9	10.9
Baricitinib	8	10.8	10.9
Metronidazole Topical	37	10.3	10.3
Everolimus Tablets	13	10.2	10.2
Voriconazole	23	10.0	10.0
Obinutuzumab	12	9.6	9.6
Temozolomide	15	9.3	9.3
Micafungin Sodium	6	9.2	9.2
Ifosfamide	15	9.2	9.2
Remdesivir	9	8.8	8.8
Levofloxacin	39	8.6	8.6
Levofloxacin In 5% Dextrose	39	8.6	8.6
Mesna Injection	5	7.9	7.9
Mesna	5	7.7	7.8
Etoposide	42	7.6	7.6
Imatinib	10	7.4	7.4
Doxorubicin Hydrochloride	18	7.2	7.2
Thalidomide	20	7.2	7.2
Dasatinib	19	6.7	6.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.